Product Code: ETC335124 | Publication Date: Aug 2023 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
The India Nuclear Medicine Market is projected to witness mixed growth rate patterns during 2025 to 2029. Growth accelerates to 14.69% in 2027, following an initial rate of 13.96%, before easing to 13.61% at the end of the period.
The India nuclear medicine market size was valued at USD 0.53 billion in 2018 and is expected to grow at a CAGR of 10% during 2025?2025 to reach USD 1 billion by 2025 driven by rising incidences chronic diseases like cancer; increasing number of diagnostic imaging centers; growing prevalence of cardiovascular diseases (CVDs); surging aging population; technological advancements; government initiatives for healthcare infrastructure development along with increased public awareness about nuclear medicine modalities will boost the growth prospects for players operating within this industry over the forecast period 2025-2031.
The India nuclear medicine market is expected to grow due to several driving factors. Nuclear medicine involves the use of radioactive substances for diagnostic and therapeutic purposes. The increasing prevalence of chronic diseases, advancements in medical imaging technologies, and the growing demand for accurate diagnostic tools are driving the adoption of nuclear medicine procedures. Additionally, investments in healthcare infrastructure, rising awareness about early disease detection, and the development of personalized medicine approaches contribute to the positive outlook of the market.
The India nuclear medicine market plays a significant role in diagnostic and therapeutic applications in healthcare. However, challenges exist. Ensuring the safe handling and disposal of radioactive materials used in nuclear medicine is a critical challenge. Regulatory compliance, patient safety, and the public`s perception of nuclear medicine`s safety are ongoing concerns. Balancing the benefits of accurate diagnosis and treatment with addressing safety and ethical concerns is a complex challenge.
The India nuclear medicine market, an integral part of the healthcare sector, faced challenges as non-emergency medical procedures were deferred during the pandemic. Imaging and diagnostic services were impacted. As healthcare services normalize, the market is expected to regain momentum, driven by advancements in medical technology and the growing importance of accurate diagnostics.
The India nuclear medicine market is evolving with advancements in medical imaging and diagnostics. Key players like GE Healthcare, Siemens Healthineers, and Curium Pharma contribute to this market by providing radiopharmaceuticals and imaging equipment. These companies play a vital role in enhancing medical diagnostics and treatment through nuclear medicine technologies.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Nuclear Medicine Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Nuclear Medicine Market Revenues & Volume, 2021 & 2031F |
3.3 India Nuclear Medicine Market - Industry Life Cycle |
3.4 India Nuclear Medicine Market - Porter's Five Forces |
3.5 India Nuclear Medicine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 India Nuclear Medicine Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 India Nuclear Medicine Market Revenues & Volume Share, By Volume Assessment, 2021 & 2031F |
4 India Nuclear Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases such as cancer and cardiovascular disorders, driving the demand for nuclear medicine diagnostics and treatments. |
4.2.2 Technological advancements in imaging techniques and radiopharmaceuticals leading to improved accuracy and effectiveness in diagnosis and treatment. |
4.2.3 Growing investments in healthcare infrastructure and increasing awareness about the benefits of nuclear medicine procedures among patients and healthcare providers. |
4.3 Market Restraints |
4.3.1 High costs associated with nuclear medicine procedures and equipment, limiting adoption rates among lower-income populations. |
4.3.2 Regulatory challenges and safety concerns regarding the use of radioactive materials in nuclear medicine applications. |
4.3.3 Limited availability of skilled professionals and specialized training programs for nuclear medicine practitioners, hindering market growth. |
5 India Nuclear Medicine Market Trends |
6 India Nuclear Medicine Market, By Types |
6.1 India Nuclear Medicine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 India Nuclear Medicine Market Revenues & Volume, By Type, 2021-2031F |
6.1.3 India Nuclear Medicine Market Revenues & Volume, By Diagnostic Nuclear Medicine, 2021-2031F |
6.1.4 India Nuclear Medicine Market Revenues & Volume, By Therapeutic Nuclear Medicine, 2021-2031F |
6.1.5 India Nuclear Medicine Market Revenues & Volume, By Brachytherapy Isotopes, 2021-2031F |
6.2 India Nuclear Medicine Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 India Nuclear Medicine Market Revenues & Volume, By Diagnostic Applications, 2021-2031F |
6.3 India Nuclear Medicine Market, By Volume Assessment |
6.3.1 Overview and Analysis |
6.3.2 India Nuclear Medicine Market Revenues & Volume, By Diagnostic Procedures, 2021-2031F |
6.3.3 India Nuclear Medicine Market Revenues & Volume, By Therapeutic Procedures, 2021-2031F |
7 India Nuclear Medicine Market Import-Export Trade Statistics |
7.1 India Nuclear Medicine Market Export to Major Countries |
7.2 India Nuclear Medicine Market Imports from Major Countries |
8 India Nuclear Medicine Market Key Performance Indicators |
8.1 Patient wait times for nuclear medicine procedures, indicating efficiency and accessibility of services. |
8.2 Adoption rates of new radiopharmaceuticals and imaging technologies in the market, reflecting technological advancements and market acceptance. |
8.3 Number of nuclear medicine facilities and clinics across different regions in India, indicating market penetration and accessibility of services. |
9 India Nuclear Medicine Market - Opportunity Assessment |
9.1 India Nuclear Medicine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 India Nuclear Medicine Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 India Nuclear Medicine Market Opportunity Assessment, By Volume Assessment, 2021 & 2031F |
10 India Nuclear Medicine Market - Competitive Landscape |
10.1 India Nuclear Medicine Market Revenue Share, By Companies, 2024 |
10.2 India Nuclear Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |